-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Reiterates Market Outperform on IDEAYA Biosciences, Maintains $42 Price Target

Benzinga·09/01/2026 13:32:13
Listen to the news
Citizens analyst Silvan Turkcan reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Market Outperform and maintains $42 price target.